TD Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-18,000
| Closed | -$425K | – | 1418 |
|
|
2016
Q2 | $425K | Sell |
18,000
-600
| -3% | -$14.2K | ﹤0.01% | 1166 |
|
|
2016
Q1 | $379K | Buy |
18,600
+10,700
| +135% | +$218K | ﹤0.01% | 1173 |
|
|
2015
Q4 | $406K | Sell |
7,900
-3,900
| -33% | -$200K | ﹤0.01% | 1161 |
|
|
2015
Q3 | $503K | Buy |
11,800
+700
| +6% | +$29.8K | ﹤0.01% | 1065 |
|
|
2015
Q2 | $506K | Buy |
11,100
+200
| +2% | +$9.12K | ﹤0.01% | 1108 |
|
|
2015
Q1 | $414K | Hold |
10,900
| – | – | ﹤0.01% | 1157 |
|
|
2014
Q4 | $309K | Sell |
10,900
-800
| -7% | -$22.7K | ﹤0.01% | 1219 |
|
|
2014
Q3 | $296K | Sell |
11,700
-5,300
| -31% | -$134K | ﹤0.01% | 1156 |
|
|
2014
Q2 | $496K | Sell |
17,000
-800
| -4% | -$23.3K | ﹤0.01% | 1032 |
|
|
2014
Q1 | $461K | Hold |
17,800
| – | – | ﹤0.01% | 1060 |
|
|
2013
Q4 | $458K | Hold |
17,800
| – | – | ﹤0.01% | 1040 |
|
|
2013
Q3 | $476K | Buy |
+17,800
| New | +$476K | ﹤0.01% | 988 |
|